Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Herbals making therapeutic claims should be Rx or OTC drugs, CSPI tells commission.

This article was originally published in The Tan Sheet

Executive Summary

HERBALS MAKING THERAPEUTIC CLAIMS SHOULD BE Rx OR OTC DRUGS, CSPI suggests in Aug. 4 comments responding to the President's Commission on Dietary Supplement Labels draft report on dietary supplement labeling, claims and safety. "We urge the commission to recommend that the FDA categorize herbal products making therapeutic claims as either prescription or over-the-counter drugs, depending upon whether such products can be used safely without medical supervision," the Center for Science in the Public Interest says. The draft report was issued June 4 ("The Tan Sheet" June 30, pp. 17-25). CSPI is a non-profit consumer group with 1 mil. members.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087398

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel